[Long-term prognosis in patients with acute non-ST-segment elevation myocardial infarction depending on dynamics of

Insights

Persistent diffuse changes in myocardial tissue dopplerography (MTD) after non-ST elevation acute myocardial infarction (AMI) indicate a poor long-term prognosis, increasing the risk of cardiac failure and silent left ventricular dysfunction.

Area of Science:

  • Cardiology
  • Echocardiography
  • Myocardial Infarction

Background:

  • Non-ST elevation acute myocardial infarction (NSTEMI) requires understanding long-term prognostic indicators.
  • Myocardial tissue dopplerography (MTD) assesses myocardial function and can reveal subtle changes post-infarction.

Purpose of the Study:

  • To investigate the long-term prognosis of patients with NSTEMI based on changes in MTD during treatment.
  • To correlate MTD patterns with the development of congestive cardiac failure (CCF) and asymptomatic left ventricular (LV) dysfunction.

Main Methods:

  • Echocardiography with MTD was performed on 88 NSTEMI patients and 34 healthy controls.
  • MTD measurements of systolic and diastolic velocities were taken at multiple LV wall levels.
  • Patients were followed for 10-18 months post-discharge to assess long-term outcomes.

Main Results:

  • NSTEMI patients were categorized into subgroups based on MTD patterns: asymmetric decrease (19.3%), diffuse decline (69.3%), and no change (11.4%).
  • Treatment led to a reduction in diffuse MTD decline (35.3%) and an increase in asymmetric MTD (42%) and unchanged MTD (22.7%).
  • A persistent diffuse decrease in MTD was associated with a significantly higher rate of CCF and asymptomatic LV dysfunction.

Conclusions:

  • Treatment for NSTEMI can improve MTD patterns, shifting from diffuse to asymmetric or normalized patterns.
  • The persistence of diffuse MTD changes post-treatment is a significant unfavorable prognostic factor for long-term cardiac health.
  • MTD is a valuable tool for predicting long-term outcomes in NSTEMI patients.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...